Rhegen

China
Shimenjie, Jiangxi, China

Company profile

Rhegen company profile

Rhegen is a research and development of mRNA medicine and gene therapy. The business creates the platform technologies needed for nucleic acid therapeutics, such as mRNA design and synthesis and non-carrier delivery, and applies these technologies to the field of drug research and development with market potential and clinical value.

Business identity

Contact email
[email protected]
Phone number
0755-3329-1915
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Founded
2019-09-11

Headquarters

Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$14.6M
Last funding
Series B / $14.6M / 2023-01-06
Last equity funding
Series B / $14.6M
Investors
2
Lead investors
1

Founders and investors

Lead investors

Shenzhen Qianhai Woying Investment Management

Investors

HSGShenzhen Qianhai Woying Investment Management